{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T14:01:07Z","timestamp":1785074467475,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T00:00:00Z","timestamp":1778976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbcan.2026.189613","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:59:58Z","timestamp":1778889598000},"page":"189613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sexual dimorphism and estrogens in neuroendocrine neoplasms"],"prefix":"10.1016","volume":"1881","author":[{"given":"Magdalena","family":"Strachowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Jacenik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189613_bb0005","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.3390\/jcm11133794","article-title":"The increasing incidence of neuroendocrine neoplasms worldwide: current knowledge and open issues","volume":"11","author":"Rossi","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbcan.2026.189613_bb0010","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1038\/s41467-021-24812-3","article-title":"The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets","volume":"12","author":"van Riet","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189613_bb0015","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3389\/fonc.2020.00831","article-title":"Biomarkers for pancreatic neuroendocrine neoplasms (PanNENs) management \u2014 an updated review","volume":"10","author":"Bocchini","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189613_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107825","article-title":"Mutational analysis of pulmonary large cell neuroendocrine carcinoma: APC gene mutations identify a good prognostic factor","volume":"192","author":"Li","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2026.189613_bb0025","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.3390\/cancers15225466","article-title":"Epidemiology of neuroendocrine neoplasms and results of their treatment with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE \u2014 a six-year experience in high-reference polish neuroendocrine neoplasm center","volume":"15","author":"Durma","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189613_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.780716","article-title":"Biomarker landscape in neuroendocrine tumors with high-grade features: current knowledge and future perspective","volume":"12","author":"Prisciandaro","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189613_bb0035","doi-asserted-by":"crossref","first-page":"664","DOI":"10.5858\/arpa.2019-0665-RA","article-title":"What is new in the 2019 World Health Organization (WHO) classification of tumors of the digestive system","volume":"145","author":"Assarzadegan","year":"2021","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.bbcan.2026.189613_bb0040","doi-asserted-by":"crossref","first-page":"567","DOI":"10.21037\/jgo.2020.03.11","article-title":"Genetic and epigenetic alterations in pancreatic neuroendocrine tumors","volume":"11","author":"Tirosh","year":"2020","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.bbcan.2026.189613_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/ERC-21-0152","article-title":"The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms","volume":"29","author":"Venizelos","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbcan.2026.189613_bb0325","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/er.2018-00160","article-title":"Genetics and epigenetics of Gastroenteropancreatic neuroendocrine neoplasms","volume":"40","author":"Mafficini","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbcan.2026.189613_bb0330","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","article-title":"Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors","volume":"36","author":"Yachida","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bbcan.2026.189613_bb0335","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/bjc.2016.229","article-title":"Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a fox chase cancer center pilot study","volume":"115","author":"Vijayvergia","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189613_bb0340","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mpdhp.2018.02.004","article-title":"Genomic landscape in gastroenteropancreatic neuroendocrine neoplasms and its usefulness in improving the prognostic evaluation","volume":"24","author":"Marinoni","year":"2018","journal-title":"Diagn. Histopathol."},{"key":"10.1016\/j.bbcan.2026.189613_bb0345","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.3390\/cancers15082249","article-title":"Neuroendocrine tumors: genomics and molecular biomarkers with a focus on metastatic disease","volume":"15","author":"Alexander","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbcan.2026.189613_bb0350","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189613_bb0355","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1172\/JCI67963","article-title":"The genomic landscape of small intestine neuroendocrine tumors","volume":"123","author":"Banck","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189613_bb0045","doi-asserted-by":"crossref","first-page":"8238","DOI":"10.1002\/cam4.5633","article-title":"Genetic alterations of GI-NECs involving three main signaling pathways","volume":"12","author":"Dai","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbcan.2026.189613_bb0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5625\/lar.2012.28.2.71","article-title":"Functions and physiological roles of two types of estrogen receptors, ER\u03b1 and ER\u03b2, identified by estrogen receptor knockout mouse","volume":"28","author":"Lee","year":"2012","journal-title":"Lab. Anim. Res."},{"key":"10.1016\/j.bbcan.2026.189613_bb0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.molmed.2012.12.007","article-title":"Estrogen synthesis and signaling pathways during ageing: from periphery to brain","volume":"19","author":"Cui","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbcan.2026.189613_bb0060","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.3390\/ijms22084254","article-title":"Estrogen receptor functions and pathways at the vascular immune Interface","volume":"22","author":"Dama","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189613_bb0065","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.beem.2015.04.008","article-title":"Estrogen receptor alpha and beta in health and disease","volume":"29","author":"Jia","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2026.189613_bb0075","article-title":"ER\u03b1 and ER\u03b2 homodimers in the same cellular context regulate distinct transcriptomes and functions","volume":"13","author":"Song","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbcan.2026.189613_bb0125","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.3390\/ijms23095191","article-title":"Assessment of G protein-coupled Oestrogen receptor expression in normal and neoplastic human tissues using a novel rabbit monoclonal antibody","volume":"23","author":"Bubb","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189613_bb0130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mce.2010.01.030","article-title":"Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice","volume":"320","author":"Balhuizen","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbcan.2026.189613_bb0135","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1210\/en.2011-0091","article-title":"Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30\/GPER in pancreatic beta-cells","volume":"152","author":"Sharma","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbcan.2026.189613_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.12.012","article-title":"Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment","volume":"186","author":"Patel","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2026.189613_bb0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mce.2016.04.011","article-title":"The G protein-coupled estrogen receptor as a modulator of neoplastic transformation","volume":"429","author":"Jacenik","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbcan.2026.189613_bb0145","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41574-023-00822-7","article-title":"The G protein-coupled oestrogen receptor GPER in health and disease: an update","volume":"19","author":"Prossnitz","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbcan.2026.189613_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.721813","article-title":"Expression of sex hormone receptor and immune response genes in peripheral blood mononuclear cells during the menstrual cycle","volume":"12","author":"Brundin","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbcan.2026.189613_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2024.1320690","article-title":"Sex-specific outcomes in cancer therapy: the central role of hormones","volume":"6","author":"Bakhshi","year":"2024","journal-title":"Front. Med. Technol."},{"key":"10.1016\/j.bbcan.2026.189613_bb0175","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/cen.13324","article-title":"Is estrogen exposure a protective factor for pancreatic neuroendocrine tumours in female patients with multiple endocrine neoplasia syndrome type 1?","volume":"86","author":"Qiu","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.bbcan.2026.189613_bb0180","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/j.psyneuen.2013.08.005","article-title":"Cumulative estrogen exposure, number of menstrual cycles, and Alzheimer\u2019s risk in a cohort of British women","volume":"38","author":"Fox","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbcan.2026.189613_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13465","article-title":"Neuroendocrine tumours and pregnancy: real-world data from an European neuroendocrine tumour centre of excellence","volume":"37","author":"Ratnayake","year":"2025","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.bbcan.2026.189613_bb0190","series-title":"StatPearls","article-title":"Physiology, progesterone","author":"Cable","year":"2025"},{"key":"10.1016\/j.bbcan.2026.189613_bb0195","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/MPA.0000000000000203","article-title":"Expression of estrogen-induced genes and estrogen receptor beta in pancreatic neuroendocrine tumors: implications for targeted therapy","volume":"43","author":"Estrella","year":"2014","journal-title":"Pancreas"},{"key":"10.1016\/j.bbcan.2026.189613_bb0200","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4132\/jptm.2017.03.19","article-title":"Loss of progesterone receptor expression is an early tumorigenesis event associated with tumor progression and shorter survival in pancreatic neuroendocrine tumor patients","volume":"51","author":"Kim","year":"2017","journal-title":"J. Pathol. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189613_bb0205","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/1097-0142(19921101)70:9<2268::AID-CNCR2820700910>3.0.CO;2-X","article-title":"Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin","volume":"70","author":"Viale","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2026.189613_bb0210","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0046-8177(96)90303-2","volume":"27","author":"Pelosi","year":"1996","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbcan.2026.189613_bb0215","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000326820","article-title":"Immunohistochemical expression and prognostic value of ER, PR and HER2\/neu in pancreatic and small intestinal neuroendocrine tumors","volume":"93","author":"Arnason","year":"2011","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bbcan.2026.189613_bb0220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11912-021-01029-7","article-title":"Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences?","volume":"23","author":"Das","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.bbcan.2026.189613_bb0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jss.2024.07.012","article-title":"Association between female sex and better survival in Gastroenteropancreatic neuroendocrine tumors","volume":"302","author":"Chang","year":"2024","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bbcan.2026.189613_bb0225","doi-asserted-by":"crossref","first-page":"e1969","DOI":"10.1210\/clinem\/dgac001","article-title":"Sexual dimorphism in small-intestinal neuroendocrine tumors: lower prevalence of mesenteric disease in premenopausal women","volume":"107","author":"Bla\u017eevi\u0107","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2026.189613_bb0230","series-title":"What Is a Pancreatic Neuroendocrine Tumor?","year":"2026"},{"key":"10.1016\/j.bbcan.2026.189613_bb0235","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tibs.2013.05.005","article-title":"Menin: a scaffold protein that controls gene expression and cell signaling","volume":"38","author":"Matkar","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbcan.2026.189613_bb0240","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10549-009-0581-0","article-title":"Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance","volume":"122","author":"Imachi","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2026.189613_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.885895","article-title":"Gender differences in pancreatic neuroendocrine neoplasms: a retrospective study based on the population of Hubei Province, China","volume":"13","author":"Fu","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbcan.2026.189613_bb0250","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.3390\/jcm11143983","article-title":"Effect of neuroendocrine neoplasm treatment on human reproductive health and sexual function","volume":"11","author":"Zamponi","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbcan.2026.189613_bb0095","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.bbrc.2005.08.226","article-title":"Identification, cloning, and expression of human estrogen receptor-\u03b136, a novel variant of human estrogen receptor-\u03b166","volume":"336","author":"Wang","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2026.189613_bb0255","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3390\/cancers11091332","article-title":"Bone metastases in neuroendocrine neoplasms: from pathogenesis to clinical management","volume":"11","author":"Altieri","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189613_bb0260","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1002\/ijc.30400","article-title":"The epidemiology of metastases in neuroendocrine tumors","volume":"139","author":"Riihim\u00e4ki","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189613_bb0265","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1093\/ejendo\/lvae075","article-title":"Ovarian neuroendocrine tumor metastases can induce estrogen production in postmenopausal patients","volume":"191","author":"Mulders","year":"2024","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bbcan.2026.189613_bb0270","first-page":"921","article-title":"Expression pattern of CDX2, estrogen and progesterone receptors in primary gastroenteropancreatic neuroendocrine tumors and metastases","volume":"36","author":"Zimmermann","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2026.189613_bb0275","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.5858\/132.12.1889","article-title":"Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors","volume":"132","author":"Sica","year":"2008","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.bbcan.2026.189613_bb0280","article-title":"Estrogen receptors in nonfunctioning pituitary neuroendocrine tumors: review on expression and gonadotroph functions","volume":"4","author":"Tajuddin","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.bbcan.2026.189613_bb0285","doi-asserted-by":"crossref","first-page":"E1237","DOI":"10.1210\/jc.2010-3040","article-title":"In nonfunctional pituitary adenomas, estrogen receptors and slug contribute to development of invasiveness","volume":"96","author":"Zhou","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2026.189613_bb0290","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.molonc.2014.05.006","article-title":"Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis","volume":"8","author":"Xie","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bbcan.2026.189613_bb0295","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2010.08.011","article-title":"Co-expression of somatostatin receptor subtypes and estrogen receptor-\u03b1 mRNAs by non-functioning pituitary adenomas in young patients","volume":"331","author":"Nishioka","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbcan.2026.189613_bb0300","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231186041","article-title":"HORMONET: a phase II trial of Tamoxifen for estrogen\/progesterone receptor-positive neuroendocrine tumors","volume":"15","author":"Barros","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.bbcan.2026.189613_bb0305","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s12020-025-04404-7","article-title":"Tamoxifen for residual NF-PitNETs: a proof-of-concept study integrating receptor profiling, pilot trial, and target pathway analysis","volume":"90","author":"Tajuddin","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/j.bbcan.2026.189613_bb0310","series-title":"StatPearls","article-title":"Neuroendocrine Tumor Lu-177-Dotatate Therapy","author":"Paluri","year":"2025"},{"key":"10.1016\/j.bbcan.2026.189613_bb0315","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5603\/EP.2017.0015","article-title":"Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the polish network of neuroendocrine Tumours)","volume":"68","author":"Kos-Kud\u0142a","year":"2017","journal-title":"Endokrynol. Pol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26000855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:21:32Z","timestamp":1785072092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26000855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0304419X26000855"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189613","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sexual dimorphism and estrogens in neuroendocrine neoplasms","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189613"}}